Inogen (INGN) FCF Margin (2013 - 2026)
Inogen (INGN) reported FCF Margin of 8.1% for Q1 2026, up 1266.0% year-over-year from 0.59% in Q1 2025, and down 452.63% on a QoQ basis from 1.47% in Q4 2025.
Inogen (INGN) has 14 years of FCF Margin data on file, last reported at 8.1% in Q1 2026.
- Quarterly FCF Margin rose 1266.0% year-over-year to 8.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.41% (up 208.0% YoY) and the FY2025 annual result came in at 3.33%, down 409.0% from the prior year.
- FCF Margin fell to 8.1% in Q1 2026 per INGN's latest filing, from 1.47% in the prior quarter.
- Across five years, FCF Margin topped out at 8.81% in Q2 2024 and bottomed at 22.63% in Q1 2022.
- The 5-year median for FCF Margin is 1.81% (2023), against an average of 4.4%.
- The widest annual swing landed in 2022, when FCF Margin plunged 2863 bps; it then jumped 2163 bps in 2023.
- Tracing INGN's FCF Margin over 5 years: stood at 21.01% in 2022, then soared by 103 bps to 0.62% in 2023, then sank by 1368 bps to 7.89% in 2024, then jumped by 81 bps to 1.47% in 2025, then slumped by 453 bps to 8.1% in 2026.
- Per Business Quant, the three latest INGN FCF Margin figures stand at 8.1% (Q1 2026), 1.47% (Q4 2025), and 3.24% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | -8.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.10% |
| Dec 31, 2025 | -1.47% |
| Sep 30, 2025 | 3.24% |
| Jun 30, 2025 | 3.97% |
| Mar 31, 2025 | -20.76% |
| Dec 31, 2024 | -7.89% |
| Sep 30, 2024 | 8.00% |
| Jun 30, 2024 | 8.81% |
| Mar 31, 2024 | -7.77% |
| Dec 31, 2023 | 0.62% |
| Sep 30, 2023 | -1.81% |
| Jun 30, 2023 | 4.76% |
| Mar 31, 2023 | -8.82% |
| Dec 31, 2022 | -21.01% |
| Sep 30, 2022 | -7.17% |
| Jun 30, 2022 | 3.28% |
| Mar 31, 2022 | -22.63% |
| Dec 31, 2021 | 7.62% |
| Sep 30, 2021 | -5.20% |
| Jun 30, 2021 | 15.23% |
| Mar 31, 2021 | 3.61% |
| Dec 31, 2020 | 20.50% |
| Sep 30, 2020 | 4.76% |
| Jun 30, 2020 | 22.65% |
| Mar 31, 2020 | -1.13% |
| Dec 31, 2019 | 7.94% |
| Sep 30, 2019 | 18.04% |
| Jun 30, 2019 | 17.20% |
| Mar 31, 2019 | -3.06% |
| Dec 31, 2018 | 5.15% |
| Sep 30, 2018 | 19.68% |
| Jun 30, 2018 | 19.08% |
| Mar 31, 2018 | 12.86% |
| Dec 31, 2017 | 23.55% |
| Sep 30, 2017 | 22.37% |
| Jun 30, 2017 | 27.04% |
| Mar 31, 2017 | 24.04% |
| Dec 31, 2016 | 9.73% |
| Sep 30, 2016 | 16.17% |
| Jun 30, 2016 | 21.09% |
| Mar 31, 2016 | 9.45% |
| Dec 31, 2015 | 49.77% |
| Sep 30, 2015 | 24.11% |
| Jun 30, 2015 | 1.09% |
| Mar 31, 2015 | 16.32% |
| Dec 31, 2014 | 13.18% |
| Sep 30, 2014 | 9.36% |
| Jun 30, 2014 | 29.80% |
| Mar 31, 2014 | -6.34% |
| Dec 31, 2013 | 7.75% |
| Sep 30, 2013 | 49.43% |
| Jun 30, 2013 | -1.98% |
| Mar 31, 2013 | -2.98% |